Unique drug development alliance unites in US

13 July 2011 - New recommendations to protect participant safety in clinical trials of certain Alzheimer’s disease drugs in the US were published online yesterday. The recommendations were drafted by an expert working group convened by the Alzheimer’s Association through its Research Roundtable. [Read more]